Summary of Product Characteristics Updated 25-Sep-2024 | Pfizer Limited
Bacteriostatic Water for Injections
Excipient with known effect
Each 1 ml vial contains 9.45 mg/ml benzyl alcohol.
For the full list of excipients see section 6.1
Sterile solution.
None. The product is intended as a diluent for Caverject powder for solution for injection/ Alprostadil powder for solution for injection (PL 00057/0941, 0942).
Intracavernosal injection
Hypersensitivity to benzyl alcohol.
Bacteriostatic Water for Injections contains benzyl alcohol (see section 2). The preservative benzyl alcohol may cause hypersensitivity reactions.
Intravenous administration of benzyl alcohol has been associated with serious adverse events, and death in paediatric patients including neonates (“ gasping syndrome” ). Although normal therapeutic doses of this product ordinarily deliver amounts of benzyl alcohol that are substantially lower than those reported in association with the “ gasping syndrome” , the minimum amount of benzyl alcohol at which toxicity may occur is not known. Benzyl alcohol containing formulations should only be used in neonates if it is necessary and if there are no alternatives possible. Premature and low-birth weight neonates may be more likely to develop toxicity. Benzyl alcohol containing formulations should not be used for more than 1 week in children under 3 years of age unless necessary. If use of a benzyl alcohol-containing formulation of Bacteriostatic Water for Injections is necessary, it is important to consider the combined daily metabolic load of benzyl alcohol from all sources, especially in patients with liver or kidney impairment, as well as in pregnant or breast-feeding women, because of the risk of accumulation and toxicity (metabolic acidosis).
None stated.
Pregnancy
Bacteriostatic Water for Injections contains benzyl alcohol as a preservative. Benzyl alcohol can cross the placenta (see section 4.4).
Breastfeeding
Bacteriostatic Water for Injections contains benzyl alcohol as a preservative. Benzyl alcohol present in maternal serum is likely to cross into human milk and may be orally absorbed by a nursing infant (see section 4.4).
None stated.
None stated.
None stated.
None stated.
None stated.
There are no pre-clinical data of relevance to the prescriber which are additional to that already included in other sections of this Summary of Product Characteristics.
Benzyl alcohol (E1519) Ph.Eur
Water for injection Ph.Eur
None stated
3 years
Store below 25° C.
1 ml pre-filled syringe with butyl rubber plunger stopper and tip cap containing 1 ml of solution.
or
1 ml pre-filled syringe with butyl rubber plunger stopper, syringe tip cap, tamper evident seal and locking device containing 1 ml of solution.
No special requirements.
Pfizer Limited
Ramsgate Road
Sandwich
Kent, CT13 9NJ
United Kingdom
PL 00057/0934
Date of first authorisation: 29 March 2012
Date of latest renewal:
09/2024
Ref: BW 5_1
Ramsgate Road, Sandwich, Kent, CT13 9NJ
www.pfizermedicalinformation.co.uk
+44 (0)1304 616 161
+44 (0)1304 616161